Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Raj V Nagarkar"'
Autor:
Raj V Nagarkar
Publikováno v:
Journal of Head Neck & Spine Surgery. 1
Autor:
Aliaksandr Prokharau, Sungyoung Lee, Yun Ju Bae, Juan-Manuel Sancho, Larry W. Kwak, Dzhelil Osmanov, Jose Angel Hernandez Rivas, Christian Buske, Edvard Zhavrid, Bertrand Coiffier, Wojciech Jurczak, Sang Joon Lee, Won Seog Kim, Raj V Nagarkar, Jin Seok Kim, Michinori Ogura, Mamia Zodelava
Publikováno v:
Blood. 128:1807-1807
Background: CT-P10 is a biosimilar candidate to the reference rituximab product, EU-approved MabThera® and US-licensed Rituxan®. CT-P10 has an identical amino acid sequence and highly similar physicochemical and in vitro functional properties to it
Autor:
Yuriy Vinnyk, Jose Angel Hernandez Rivas, Elena Volodicheva, Samuel Fourie, Michinori Ogura, Christian Buske, Juan-Manuel Sancho, Won Seog Kim, Wojciech Jurczak, Jin Seok Kim, Raj V Nagarkar, Juan Alfonso Soler, Panagiotis Tsirigotis, Piera Viero, Edvard Zhavrid, Bertrand Coiffier
Publikováno v:
Blood. 126:5111-5111
Global phase I/III pharmacokinetic and efficacy study comparing CT-P10, a biosimilar candidate to the rituximab reference product in patients with advanced stage follicular lymphoma (AFL) CT-P10 is a biosimilar candidate to the reference rituximab pr
Autor:
Diane Provencher, M. Buck, Margaret Davy, Raj V. Nagarkar, C. H. Pippitt, Gary Richardson, Daniel E. Stepan, David M. Weinreich, Charles A. Leath, Amit M. Oza, Allan Covens, Prafull Ghatage, Vincent L. Hansen, Ignace Vergote, Yu Nien Sun, John V. Brown, Marjan Tassoudji, Hoa Nguyen, Beth Y. Karlan, Setsuko K. Chambers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(4)
Purpose To estimate the efficacy and toxicity of AMG 386, an investigational peptide-Fc fusion protein that neutralizes the interaction between the Tie2 receptor and angiopoietin-1/2, plus weekly paclitaxel in patients with recurrent ovarian cancer.